About
Prollenium Medical Technologies Inc. is a Canadian company based in Richmond Hill, Ontario, established in 2002. It specializes in the research, development, manufacturing, and distribution of hyaluronic acid (HA) dermal fillers and related medical aesthetic products. Prollenium is recognized as the only manufacturer of HA dermal fillers in North America and operates a 70,000 square foot facility dedicated to high-quality standards through rigorous testing and quality assurance. The company's flagship product line, Revanesse®, features advanced HA dermal fillers known for their optimized cross-linking technology, providing natural-looking results for facial enhancement. Prollenium also offers skin rejuvenating systems, facial aesthetics, and skincare products, catering to a diverse global customer base. Committed to innovation, Prollenium maintains all research and development and manufacturing processes in-house, ensuring strict quality control. The company is ISO 13485:2016 certified and operates FDA-approved facilities, reflecting its dedication to safety and efficacy. Prollenium supports healthcare practitioners with education, training, and customer service, fostering strong professional relationships.
Technologies
Keywords
Company Information
-
Employees 140
-
Founded 2002
-
Annual Revenue $39400000
Location
29 E Wilmot St, Richmond Hill, Ontario, Canada, L4B 1A3
